Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2023-04-25 00:00:00 ET · period of report 2023-04-21 · accession 0001140361-23-020312 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-25 | 2023-04-21 | RCKT | Militello John | See Remarks | S - Sale | $18.65 | -2,342 | 5,636 | -29% | -$43.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | S | D | 2,342 | $18.65 | 5,636 | D | — | — | (F2) This transaction was executed in multiple brokered trades at prices ranging from $18.55 to $18.88. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |